These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9744313)

  • 21. Isolation of cells entering different programmed cell death pathways using a discontinuous Percoll gradient.
    Koty PP; Zhang H; Lei W; Levitt ML
    Methods Mol Med; 2003; 74():309-26. PubMed ID: 12415705
    [No Abstract]   [Full Text] [Related]  

  • 22. Expression of p21 and bcl-2 proteins in paraffin-embedded preparations of non-small cell lung cancer in stage IIIA after Etoposide and Cisplatin induced chemotherapy.
    Mańdziuk S; Dudzisz-Sledź M; Korszeń-Pilecka I; Milanowski J; Wojcierowski J; Korobowicz E
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):149-53. PubMed ID: 15314975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis.
    Chatterjee A; Chattopadhyay D; Chakrabarti G
    Cell Signal; 2015 Feb; 27(2):189-203. PubMed ID: 25435430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer.
    Schmidt LH; Görlich D; Spieker T; Rohde C; Schuler M; Mohr M; Humberg J; Sauer T; Thoenissen NH; Huge A; Voss R; Marra A; Faldum A; Müller-Tidow C; Berdel WE; Wiewrodt R
    J Thorac Oncol; 2014 Sep; 9(9):1294-304. PubMed ID: 25036876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival.
    Laudanski J; Chyczewski L; Niklińska WE; Kretowska M; Furman M; Sawicki B; Nikliński J
    Neoplasma; 1999; 46(1):25-30. PubMed ID: 10355530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo.
    Jiang H; Zhao PJ; Su D; Feng J; Ma SL
    Mol Med Rep; 2014 Jun; 9(6):2265-72. PubMed ID: 24718383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue microarray analysis of Fas and FasL expressions in human non-small cell lung carcinomas; with reference to the p53 and bcl-2 overexpressions.
    Myong NH
    J Korean Med Sci; 2005 Oct; 20(5):770-6. PubMed ID: 16224150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
    Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D
    Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer].
    Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH
    Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent high expression of bax pro-apoptotic protein in non-small cell lung cancer.
    Caputi M; Groeger AM; Esposito V; De Luca A; Murabito M; Tahir T; Giordano GG; Baldi F; Giordano A; Wolner E
    Anticancer Res; 1999; 19(1B):825-7. PubMed ID: 10216500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer.
    Lai RS; Wang JS; Hsu HK; Chang HC; Lin CH; Lin MH
    Jpn J Clin Oncol; 2002 Oct; 32(10):393-7. PubMed ID: 12451034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy inhibition enhances pan-Bcl-2 inhibitor AT-101-induced apoptosis in non-small cell lung cancer.
    Mei H; Lin Z; Wang Y; Wu G; Song Y
    Neoplasma; 2014; 61(2):186-92. PubMed ID: 24299314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats.
    Zhong CY; Zhou YM; Douglas GC; Witschi H; Pinkerton KE
    Carcinogenesis; 2005 Dec; 26(12):2187-95. PubMed ID: 16051644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of multidrug resistance-associated gene in non-small cell lung cancer and its correlations with telomerase reverse transcriptase and genes related to apoptosis].
    Yao XF; Xiong YY; Liu L; Chen TX; Li L
    Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):110-1. PubMed ID: 15842809
    [No Abstract]   [Full Text] [Related]  

  • 36. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells.
    Kataoka M; Wiehle S; Spitz F; Schumacher G; Roth JA; Cristiano RJ
    Oncogene; 2000 Mar; 19(12):1589-95. PubMed ID: 10734319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S; Chatten J; Hanada M; Reed JC
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of immunostaining for tumour markers in non-small cell lung carcinoma.
    Macdonald C; Michael A; Colston K; Mansi J
    Eur J Cancer; 2004 Feb; 40(3):461-6. PubMed ID: 14746866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancer.
    Ko E; Kim Y; Cho EY; Han J; Shim YM; Park J; Kim DH
    Ann Surg Oncol; 2013 Mar; 20(3):1005-12. PubMed ID: 23115005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
    Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
    Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.